Health Headlines: FDA, Abortion Pills, and Bird Flu Updates

This summary covers recent health news including the US FDA panel's decision against Novo Nordisk's weekly insulin for type 1 diabetes due to low blood sugar risks, Louisiana's new law classifying abortion pills as controlled substances, US curbs on certain poultry imports from Australia due to bird flu, and findings from a Novo Nordisk study showing Wegovy's kidney-related health benefits.

Following is a summary of current health news briefs.

US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients

Advisers to the U.S. health regulator on Friday voted against the use of Novo Nordisk's weekly insulin in patients with type 1 diabetes due to risks of low blood sugar. The Food and Drug Administration's panel of independent experts voted 7-to-4, saying the weekly insulin icodec's benefits do not outweigh the risks

Explainer-What does Louisiana's new abortion pill law mean for patients?

The Louisiana Senate's vote on Thursday to reclassify the two drugs used in medication abortion as controlled substances marks the latest development in a nationwide battle over abortion pills. Here is a look at what the law does, and what might happen next.

US curbs certain poultry imports from Australia's Victoria on bird flu concerns

The U.S. has imposed import curbs on certain poultry and byproducts from Victoria, Australia after determining highly pathogenic avian influenza, or bird flu, in domestic birds. The Department of Agriculture's Animal and Plant Health Inspection Service said on Friday the restrictions from May 22 will continue until further notice.

Wegovy users have less kidney-related health problems, analysis of Novo study finds

Novo Nordisk's Wegovy obesity drug reduced adverse kidney-related events by 22% in overweight and obese people in a large study, according to a new analysis the Danish drugmaker published on Saturday. The analysis, from a large study for which substantial results had been released by Novo last year, was presented at the European Renal Congress in Stockholm.

Louisiana becomes first US state to classify abortion pills as controlled substances

Louisiana's governor on Friday signed a bill making his state the first in the U.S. to classify two abortion-inducing medications as controlled substances, a category that healthcare regulators typically reserve for drugs prone to abuse or addiction. The measure, thrusting Republican-led efforts to restrict abortion back to the political forefront in a presidential election year, was signed into law by Republican Governor Jeff Landry a day after the state legislature sent it to his desk.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)